Johnson & Johnson Divests Entire Stake in BiomX Inc.
Ticker: PHGE · Form: SC 13G/A · Filed: Feb 2, 2024 · CIK: 1739174
| Field | Detail |
|---|---|
| Company | Biomx Inc. (PHGE) |
| Form Type | SC 13G/A |
| Filed Date | Feb 2, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Sentiment | bearish |
Complexity: simple
Sentiment: bearish
Topics: institutional-ownership, divestment, biotech, ownership-change
TL;DR
**J&J sold all its BiomX shares, signaling a potential red flag for investors.**
AI Summary
Johnson & Johnson, a major pharmaceutical company, filed an amended SC 13G/A on February 2, 2024, indicating a change in their beneficial ownership of BiomX Inc. common stock as of December 31, 2023. This filing shows Johnson & Johnson now beneficially owns 0 shares of BiomX, down from a previous undisclosed amount, representing a complete divestment. This matters to investors because a large, reputable company like Johnson & Johnson selling all its shares could signal a lack of confidence in BiomX's future prospects or a strategic shift in Johnson & Johnson's investment portfolio.
Why It Matters
This complete divestment by a major pharmaceutical player like Johnson & Johnson could be interpreted negatively by the market, potentially impacting BiomX's stock price and investor sentiment.
Risk Assessment
Risk Level: medium — The complete divestment by a significant institutional investor like Johnson & Johnson introduces uncertainty and potential downward pressure on BiomX's stock.
Analyst Insight
A smart investor would closely monitor BiomX Inc.'s stock performance and news for any further developments or explanations regarding Johnson & Johnson's complete divestment, and consider if this signals deeper issues before making investment decisions.
Key Numbers
- 0 — shares beneficially owned by Johnson & Johnson (This indicates a complete divestment of their previous holdings in BiomX Inc.)
Key Players & Entities
- Johnson & Johnson (company) — the reporting person who divested shares
- BiomX Inc. (company) — the issuer whose shares were divested
- December 31, 2023 (date) — the date of the event requiring the filing
- New Jersey (company) — place of organization for Johnson & Johnson
Forward-Looking Statements
- BiomX Inc.'s stock price may experience downward pressure in the short term. (BiomX Inc.) — medium confidence, target: Q1 2024
- Other institutional investors might re-evaluate their positions in BiomX Inc. (BiomX Inc.) — low confidence, target: Q2 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, used to report beneficial ownership of 5% or more of a company's stock by certain investors.
Who is the 'Reporting Person' in this filing?
The 'Reporting Person' is Johnson & Johnson, a company organized in New Jersey, as stated on the cover page of the filing.
What is the 'Name of Issuer' mentioned in this filing?
The 'Name of Issuer' is BiomX Inc., with Common Stock, $.0001 par value, as the 'Title of Class of Securities'.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, as specified on the cover page.
What is the CUSIP Number for BiomX Inc. securities?
The CUSIP Number for BiomX Inc. is 09090D103, as listed on the cover page of the filing.
Filing Stats: 769 words · 3 min read · ~3 pages · Grade level 7.8 · Accepted 2024-02-02 17:07:42
Filing Documents
- s13ga_012224-biomxinc.htm (SC 13G/A) — 34KB
- 0000904454-24-000096.txt ( ) — 36KB
(b). Address of Issuer’s Principal Executive Offices
Item 1(b). Address of Issuer’s Principal Executive Offices 22 Einstein Street, Floor 4, Ness Ziona, Israel
(c). Citizenship
Item 2(c). Citizenship J&J: New Jersey JJDC: Delaware
Ownership
Item 4. Ownership (a) through (c): The information requested in these paragraphs is incorporated by reference to the cover pages to this Amendment No. 1 to Schedule 13G.
Ownership of Five Percent or Less of the Class
Item 5. Ownership of Five Percent or Less of the Class If this statement is being filed to report the fact that the Reporting Persons have ceased to be the beneficial owners of more than five percent of the Common Stock, check the following: [X] CUSIP No. 09090D103 13G Page 5 of 5 SIGNATURE After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: February 2, 2024 JOHNSON & JOHNSON By: /s/ Marc Larkins Name: Marc Larkins Title: Secretary JOHNSON & JOHNSON INNOVATION-JJDC, INC. By: /s/ Jill McManus Name: Jill McManus Title: Assistant Treasurer